Open access
Jul 2026
Hitting the bullseye: PSMA-targeted small molecule drug conjugate for prostate cancer treatment
DUPA-SS-Exa is established as a stable, highly specific, and potent therapeutic strategy for PSMA-expressing tumors with a favorable safety profile and is stable at acidic pH, in PBS, and in serum.
Dhanashree Murugan, Loganathan Rangasamy
· RSC Advances · 0 citations